Comparison of circuit patency and exchange rates between 2 different continuous renal replacement therapy machines
Author:
Publisher
Elsevier BV
Subject
Critical Care and Intensive Care Medicine
Reference23 articles.
1. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis;Hoste;Crit Care,2006
2. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients;Metnitz;Crit Care Med,2002
3. The RIFLE criteria and mortality in acute kidney injury: a systematic review;Ricci;Kidney Int,2008
4. Intensity of continuous renal-replacement therapy in critically ill patients;Investigators RRTS;N Engl J Med,2009
5. Intensity of renal support in critically ill patients with acute kidney injury;Network VNARFT;N Engl J Med,2008
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparison of circuit patency and exchange rates between the original and generic versions of nafamostat mesylate in critically ill adults receiving continuous renal replacement therapy;Kosin Medical Journal;2023-03-31
2. Renal Replacement Therapy in Acute Kidney Injury;Evidence‐Based Nephrology;2022-11-18
3. Anticoagulation Strategies and Filter Life in COVID-19 Patients Receiving Continuous Renal Replacement Therapy;Clinical Journal of the American Society of Nephrology;2020-09-17
4. Prognostic Factors and Efficacy for Continuous Renal Replacement Therapy in Critically Ill Patients: A Chinese Single-Center Retrospective Study;Blood Purification;2017-12-07
5. Continuous Renal Replacement Therapy: Reviewing Current Best Practice to Provide High-Quality Extracorporeal Therapy to Critically Ill Patients;Advances in Chronic Kidney Disease;2017-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3